Andrew D Sklawer Brickell Biotech, Inc. (BBI) insider trading activity

BBI Quotes by TradingView

Andrew D Sklawer is President and CEO of Brickell Biotech, Inc.. Currently has a direct ownership of 39,269 shares of BBI, which is worth approximately $69,113. The most recent transaction as insider was on Oct 02, 2023, when has been sold 20,833 shares (Common Stock) at a price of $0.98 per share, resulting in proceeds of $20,416. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.3K
0% 3M change
0% 12M change
Total Value Held $69,113

Andrew D Sklawer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 02 2023
SELL
Payment of exercise price or tax liability
$20,416 $0.98 p/Share
20,833 Reduced 34.66%
39,269 Common Stock
Oct 02 2023
BUY
Exercise of conversion of derivative security
-
55,000 Added 47.78%
60,102 Common Stock
May 17 2021
BUY
Open market or private purchase
$12,300 $0.8 p/Share
15,375 Added 10.98%
124,625 Common Stock
Mar 16 2021
SELL
Payment of exercise price or tax liability
$7,980 $1.14 p/Share
7,000 Reduced 6.02%
109,250 Common Stock
Mar 16 2021
BUY
Exercise of conversion of derivative security
-
20,000 Added 14.68%
116,250 Common Stock
ADS

Andrew D Sklawer

President and CEO
Boulder, CO

Track Institutional and Insider Activities on BBI

Follow Brickell Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBI shares.

Notify only if

Insider Trading

Get notified when an Brickell Biotech, Inc. insider buys or sells BBI shares.

Notify only if

News

Receive news related to Brickell Biotech, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BBI